Cytochrome P-450 CYP2A6 Inhibitors (weak)
- Name
- Cytochrome P-450 CYP2A6 Inhibitors (weak)
- Accession Number
- DBCAT003897
- Description
Not Available
- Drugs
Drug Drug Description Memantine An NMDA receptor antagonist used to treat moderate to severe dementia in Alzheimer's. Methimazole A thionamide antithyroid agent that inhibits the actions of thyroid peroxidase, leading to a reduction in thyroid hormone synthesis and amelioration of hyperthyroidism. Amphetamine A CNS stimulant and sympathomimetic agent indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Fenofibrate A peroxisome proliferator receptor alpha activator used to lower LDL-C, total-C, triglycerides, and Apo B, while increasing HDL-C in hypercholesterolemia, dyslipidemia, and hypertriglyceridemia. Ethambutol An antituberculosis agent used in the prophylaxis and treatment of tuberculosis (TB). Cannabidiol An active cannabinoid used as an adjunctive treatment for the management of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome and symptomatic relief of moderate to severe neuropathic pain or other painful conditions, like cancer. - Drugs & Drug Targets